Genes & biomarkers
EGFR variants
EGFR · exon 19 / L858R / exon 20
In lung cancer, the precise EGFR alteration matters.
Sources checked · Introductory guide
On this page
What does this result mean?
EGFR is a receptor for growth signals. In non-small cell lung cancer, changes such as exon 19 deletions or exon 21 variants can keep it active.[1]
How does it connect to treatment?
EGFR inhibitors such as osimertinib are used for selected EGFR-altered non-small cell lung cancers. Eligibility differs after surgery, after certain chemoradiation and in metastatic disease.[2]
What should I check in my report?
Distinguish exon 19 deletion, L858R and exon 20 insertion. If a new finding appears during treatment, ask how it relates to the original variant and possible resistance.
Questions for your care team
- What is my exact EGFR variant and which drug criteria does it meet?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.